Application of Nanopore Adaptive Sequencing

Infection post liver transplantation is an important factor in the death in patients. The traditional method of diagnosing infection post liver transplantation is laboratory tests. But the sensitivity and specificity of blood tests is poor. Next-generation sequencing (NGS) has greater detection rate for mycobacterium tuberculosis, anaerobes and fungi and greater sensitivity compare with blood tests. However use of NGS is limited because of the short read-length. Oxford nanopore adaptive sequencing (NAS) method is the Third Revolution in Sequencing Technology. For each 1 Gbp of data, NAS sequencing detected 45 times more microbiome sequences than Nanopore standard sequencing and 2.5 times more than Illumina sequencing. The purpose of this study is to compare NAS with NGS and laboratory tests for the diagnostic rate of infection post liver transplantation.

NCT Number	NCT06542042
Lead Sponsor	Shenzhen Third People's Hospital
Conditions	Liver Transplant Infection
Enrollment	100 participants
Start Date	2024-10-01
Primary Completion	2026-08-01 (estimated)
Study Completion	2026-10-30 (estimated)
Updated on ClinicalTrials.gov	2024-08-07